<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Clinics (Sao Paulo)</journal-id>
      <journal-title-group>
        <journal-title>Clinics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1807-5932</issn>
      <issn pub-type="epub">1980-5322</issn>
      <publisher>
        <publisher-name>Hospital das Cl&#xED;nicas da Faculdade de Medicina da Universidade de S&#xE3;o Paulo</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21049221</article-id>
      <article-id pub-id-type="pmc">2954744</article-id>
      <article-id pub-id-type="doi">10.1590/S1807-59322010000900016</article-id>
      <article-id pub-id-type="publisher-id">cln_65p923</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Glioblastoma multiforme in childhood: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Borgo</surname>
            <given-names>Mauro Cruz Machado</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cln_65p923">I</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pereira</surname>
            <given-names>Julio Leonardo Barbosa</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cln_65p923">I</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Lima</surname>
            <given-names>Franklin Bernardes Faraj</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cln_65p923">I</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brand&#xE3;o</surname>
            <given-names>Rafael Augusto Castro Santiago</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cln_65p923">I</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Carvalho</surname>
            <given-names>Gerv&#xE1;sio Teles C</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cln_65p923">I,</xref>
          <xref ref-type="aff" rid="af2-cln_65p923">II</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Costa</surname>
            <given-names>Bruno Silva</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cln_65p923">I</xref>
        </contrib>
        <aff id="af1-cln_65p923"><label>I</label>Santa Casa de Belo Horizonte, Belo Horizonte, MG, Brazil.</aff>
        <aff id="af2-cln_65p923"><label>II</label>Faculty of Medical Sciences of Minas Gerais, Belo Horizonte, MG, Brazil.</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1-cln_65p923">E-mail: <email>maurocmborgo@hotmail.com</email> Tel.: <phone>55 31 3238-8896</phone></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2010</year>
      </pub-date>
      <volume>65</volume>
      <issue>9</issue>
      <fpage>923</fpage>
      <lpage>925</lpage>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2010 Hospital das Cl&#xED;nicas da FMUSP</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <counts>
        <page-count count="3"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="" id="s1">
      <title>INTRODUCTION</title>
      <p>Among high-grade gliomas, childhood glioblastoma multiforme (GBM) is particularly challenging in terms of therapeutic treatment.<xref ref-type="bibr" rid="b1-cln_65p923">1</xref>-<xref ref-type="bibr" rid="b5-cln_65p923">5</xref> Cerebral tumors are the most frequent childhood solid neoplastic disorders and are the primary cancer-related cause of death among children.<xref ref-type="bibr" rid="b1-cln_65p923">1</xref>,<xref ref-type="bibr" rid="b3-cln_65p923">3</xref> Gliomas constitute approximately 60% of all cerebral tumors, and approximately half of them are considered to be high-grade malignant tumors.<xref ref-type="bibr" rid="b1-cln_65p923">1</xref> The prognosis for recovery is conservative, and 5-year survival rates range from 5% to 15%.<xref ref-type="bibr" rid="b2-cln_65p923">2</xref>,<xref ref-type="bibr" rid="b6-cln_65p923">6</xref>,<xref ref-type="bibr" rid="b7-cln_65p923">7</xref> This case report documents a GBM that was located deep in the right cerebral hemisphere of a 9-year-old child. Because this is a rare illness for a patient of this age, we also provide a brief literature review to supplement this case report.</p>
    </sec>
    <sec sec-type="" id="s2">
      <title>CASE REPORT</title>
      <p>A previously healthy 9-year-old girl with adequate neuropsychomotor development was admitted to the hospital with a 15-day-long hemiparesis and disorientation. A skull computerized tomography (CT) scan showed a deep-seated, irregularly shaped expansive lesion on the right of brain, with peripheral contrast uptake that was impinging on and obstructing the cerebrospinal fluid (CSF) pathways (see <xref ref-type="fig" rid="f1-cln_65p923">Figure 1</xref>). We performed a ventriculoperitoneal shunting and stereoctatic biopsy of the lesion. The histopathology showed a pleomorphic neoplasia, which was associated with vascular neoformation, and necrosis with elongated cells and hyperchromatic and pleomorphic nuclei that had atypia and mitotic figures. The immunohistochemistry (see <xref ref-type="table" rid="t1-cln_65p923">Table 1</xref>) was positive for the glial fibrillary acidic protein (GFAP), Ki-67 proliferation antigen, and S-100 protein. These findings, along with the morphological features and the presence of necrosis, confirmed the diagnosis of GBM (see <xref ref-type="fig" rid="f2-cln_65p923">Figure 2</xref>). The patient, whose level of consciousness improved with steroids but whose motor functioning remained impaired, was referred to radiotherapy. After 40 days, there was a significant neurological worsening with hemiplegia and a fluctuating level of consciousness. Skull CT and MRI results showed an increase of the lesion size (see <xref ref-type="fig" rid="f3-cln_65p923">Figure 3</xref>). A craniotomy with a partial tumor removal was performed to reduce the intracranial hypertension. The patient died ten days after the procedure.</p>
    </sec>
    <sec sec-type="" id="s3">
      <title>DISCUSSION</title>
      <p>Malignant gliomas are rare in childhood, comprising approximately 6.5% of all intracranial neoplastic disorders in the pediatric population. Although these gliomas may occur in any anatomical site within the central nervous system, they are most frequently located in the supratentorial site.<xref ref-type="bibr" rid="b1-cln_65p923">1</xref>,<xref ref-type="bibr" rid="b3-cln_65p923">3</xref>,<xref ref-type="bibr" rid="b5-cln_65p923">5</xref> Males are slightly more affected than females (male:female ratio &#x200A;=&#x200A; 1.5:1). In terms of histology, anaplastic astrocytomas are characterized by hypercellularity, nuclear atypia, mytotic figures, nuclear pleomorphism and vascular proliferation; GBM also has associated necrosis.<xref ref-type="bibr" rid="b2-cln_65p923">2</xref>,<xref ref-type="bibr" rid="b6-cln_65p923">6</xref>       </p>
      <p>Children with high-grade gliomas present with a variety of signs and symptoms that chiefly depend on their age and the tumor localization. The rate of neurological impairment is characteristically quick and may range from months to days. Seizures may herald the onset, especially when tumors are close to the cerebral cortex. Other common clinical manifestations include hemiparesis, visual deficit, headache, and, in some cases, signs of intracranial hypertension due to an obstruction of the CSF pathways.<xref ref-type="bibr" rid="b2-cln_65p923">2</xref>-<xref ref-type="bibr" rid="b8-cln_65p923">8</xref> In our case, the first clinical manifestation was hemiparesis and clouding of the consciousness, with rapidly evolving intracranial hypertension despite partial removal of the tumor.</p>
      <p>A brain MRI is the investigational tool of choice for determining a GBM diagnosis.<xref ref-type="bibr" rid="b1-cln_65p923">1</xref>-<xref ref-type="bibr" rid="b3-cln_65p923">3</xref>,<xref ref-type="bibr" rid="b8-cln_65p923">8</xref> In this case, there was an irregularly outlined, deep-seated cerebral lesion with a mass effect, peripheral contrast uptake and central necrosis. Such findings are consistent with the literature.<xref ref-type="bibr" rid="b1-cln_65p923">1</xref>,<xref ref-type="bibr" rid="b3-cln_65p923">3</xref>       </p>
      <p>The treatment of malignant gliomas is still a challenge, particularly in children. Chemotherapy and radiotherapy, far from being satisfactory treatment options, are associated with a significant rate of morbidity.<xref ref-type="bibr" rid="b9-cln_65p923">9</xref>-<xref ref-type="bibr" rid="b12-cln_65p923">12</xref> Present day treatment includes tumor resection, local radiotherapy, and chemotherapy, which are approaches that promote an improvement in the length of survival but do not seem to change the inexorable course of the disease.<xref ref-type="bibr" rid="b1-cln_65p923">1</xref>,<xref ref-type="bibr" rid="b3-cln_65p923">3</xref>-<xref ref-type="bibr" rid="b5-cln_65p923">5</xref>,<xref ref-type="bibr" rid="b13-cln_65p923">13</xref>,<xref ref-type="bibr" rid="b14-cln_65p923">14</xref>       </p>
      <p>Our patient developed obstructive hydrocephalus that demanded ventriculoperitoneal shunting. A subsequent stereotactic biopsy led to the histopathological confirmation of GBM. We chose to perform radiotherapy and chemotherapy. The quick, unfavorable evolution of the disease precluded the use of chemotherapy and led us to try a partial tumor resection for decompression, which was ultimately unsuccessful.</p>
      <p>The role of adjuvant chemotherapy for the treatment of pediatric high grade gliomas (HGGs) was established in the 1980s,<xref ref-type="bibr" rid="b15-cln_65p923">15</xref> which is based on the results of a randomized Children's Cancer Group study using lomustine and vincristine. Recently, studies have shown a small increase in survival rates using temozolomide and lomustine to treat pediatric HGGs.<xref ref-type="bibr" rid="b16-cln_65p923">16</xref> These studies have demonstrated that surgery, chemotherapy, and radiotherapy were ineffective in achieving long-term survival. There have only been anecdotal reports of good results in the treatment of glioblastoma in children. Further research on this disease is needed so that better treatments may be developed to improve the quality of life and prognosis of these patients.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="b1-cln_65p923">
        <label>1</label>
        <element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Reddy</surname><given-names>AT</given-names></name><name><surname>Wellons</surname><given-names>JC</given-names></name></person-group><article-title>Pediatric high-grade gliomas</article-title><source>The Cancer Journal</source><year>2003</year><volume>9</volume><fpage>107</fpage><lpage>12</lpage><ext-link ext-link-type="doi" xlink:href="10.1097/00130404-200303000-00006">10.1097/00130404-200303000-00006</ext-link> 	<pub-id pub-id-type="pmid">12784876</pub-id></element-citation>
      </ref>
      <ref id="b2-cln_65p923">
        <label>2</label>
        <element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Rondinelli</surname><given-names>PIP</given-names></name><name><surname>Martinez</surname><given-names>CAO</given-names></name></person-group><article-title>Met&#xE1;stases intrarraquidianas de glioblastoma multiforme supratentorial da inf&#xE2;ncia: relato de caso</article-title><source>Arq Neuro-Psiquiatr</source><year>2002</year><volume>60</volume><fpage>643</fpage><lpage>6</lpage></element-citation>
      </ref>
      <ref id="b3-cln_65p923">
        <label>3</label>
        <element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Tamber</surname><given-names>MS</given-names></name><name><surname>Rutka</surname><given-names>JT</given-names></name></person-group><article-title>Pediatric supratentorial high-grade gliomas</article-title><source>Neurosurg Focus</source><year>2003</year><volume>14</volume><issue>(2)</issue><fpage>e1</fpage><ext-link ext-link-type="doi" xlink:href="10.3171/foc.2003.14.2.2">10.3171/foc.2003.14.2.2</ext-link> 	<pub-id pub-id-type="pmid">15727422</pub-id></element-citation>
      </ref>
      <ref id="b4-cln_65p923">
        <label>4</label>
        <element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Pollack</surname><given-names>IF</given-names></name></person-group><article-title>The role of surgery in pediatric gliomas</article-title><source>J Neuro-Oncol</source><year>1999</year><volume>42</volume><fpage>271</fpage><lpage>88</lpage><ext-link ext-link-type="doi" xlink:href="10.1023/A:1006107227856">10.1023/A:1006107227856</ext-link> 	</element-citation>
      </ref>
      <ref id="b5-cln_65p923">
        <label>5</label>
        <element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Artico</surname><given-names>M</given-names></name><name><surname>Cervoni</surname><given-names>L</given-names></name><name><surname>Celli</surname><given-names>P</given-names></name><name><surname>Salvati</surname><given-names>M</given-names></name><name><surname>Palma</surname><given-names>L</given-names></name></person-group><article-title>Supratentorial glioblastoma in children: a series of 27 surgically treated cases</article-title><source>Childs Nerv Syst</source><year>1993</year><volume>9</volume><fpage>7</fpage><lpage>9</lpage><ext-link ext-link-type="doi" xlink:href="10.1007/BF00301926">10.1007/BF00301926</ext-link> 	<pub-id pub-id-type="pmid">8481945</pub-id></element-citation>
      </ref>
      <ref id="b6-cln_65p923">
        <label>6</label>
        <element-citation publication-type="book">             <person-group person-group-type="author"><name><surname>Kleihues</surname><given-names>P</given-names></name><name><surname>Cavenne</surname><given-names>W</given-names></name></person-group><source>Pathology and Genetics of Tumors of the Central Nervous System.</source><year>1997</year><publisher-loc>Lyon, France</publisher-loc><publisher-name>International Agency for Research on Cancer</publisher-name></element-citation>
      </ref>
      <ref id="b7-cln_65p923">
        <label>7</label>
        <element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Wrensch</surname><given-names>M</given-names></name><name><surname>Minn</surname><given-names>Y</given-names></name><name><surname>Chew</surname><given-names>T</given-names></name><name><surname>Bondy</surname><given-names>M</given-names></name><name><surname>Berger</surname><given-names>MS</given-names></name></person-group><article-title>Epidemiology of primary brain tumors: current concepts and review of the literature</article-title><source>Neuro-Oncol</source><year>2002</year><volume>4</volume><fpage>278</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">12356358</pub-id></element-citation>
      </ref>
      <ref id="b8-cln_65p923">
        <label>8</label>
        <element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Dropcho</surname><given-names>EJ</given-names></name><name><surname>Wisoff</surname><given-names>JH</given-names></name><name><surname>Walker</surname><given-names>RW</given-names></name><name><surname>Allen</surname><given-names>JC</given-names></name></person-group><article-title>Supratentorial malignant gliomas in childhood: a review of fifty cases</article-title><source>Ann Neurol</source><year>1987</year><volume>22</volume><fpage>355</fpage><lpage>64</lpage><ext-link ext-link-type="doi" xlink:href="10.1002/ana.410220312">10.1002/ana.410220312</ext-link> 	<pub-id pub-id-type="pmid">2823687</pub-id></element-citation>
      </ref>
      <ref id="b9-cln_65p923">
        <label>9</label>
        <element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Wisoff</surname><given-names>JH</given-names></name><name><surname>Boyett</surname><given-names>JM</given-names></name><name><surname>Berger</surname><given-names>MS</given-names></name><name><surname>Brant</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Yates</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945</article-title><source>J Neurosurg</source><year>1998</year><volume>89</volume><fpage>52</fpage><lpage>9</lpage><ext-link ext-link-type="doi" xlink:href="10.3171/jns.1998.89.1.0052">10.3171/jns.1998.89.1.0052</ext-link> 	<pub-id pub-id-type="pmid">9647172</pub-id></element-citation>
      </ref>
      <ref id="b10-cln_65p923">
        <label>10</label>
        <element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Kreth</surname><given-names>FW</given-names></name><name><surname>Warnke</surname><given-names>PC</given-names></name><name><surname>Scheremet</surname><given-names>R</given-names></name><name><surname>Ostertag</surname><given-names>CB</given-names></name></person-group><article-title>Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme</article-title><source>J Neurosurg</source><year>1993</year><volume>78</volume><fpage>762</fpage><lpage>6</lpage><ext-link ext-link-type="doi" xlink:href="10.3171/jns.1993.78.5.0762">10.3171/jns.1993.78.5.0762</ext-link> 	<pub-id pub-id-type="pmid">8385709</pub-id></element-citation>
      </ref>
      <ref id="b11-cln_65p923">
        <label>11</label>
        <element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Phuphanich</surname><given-names>S</given-names></name><name><surname>Edwards</surname><given-names>MS</given-names></name><name><surname>Levin</surname><given-names>VA</given-names></name><name><surname>Vestnys</surname><given-names>PS</given-names></name><name><surname>Wara</surname><given-names>WM</given-names></name><name><surname>Davis</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Supratentorial malignant gliomas of childhood. Results of treatment with radiation therapy and chemotherapy</article-title><source>J Neurosurg</source><year>1984</year><volume>60</volume><fpage>495</fpage><lpage>9</lpage><ext-link ext-link-type="doi" xlink:href="10.3171/jns.1984.60.3.0495">10.3171/jns.1984.60.3.0495</ext-link> 	<pub-id pub-id-type="pmid">6699693</pub-id></element-citation>
      </ref>
      <ref id="b12-cln_65p923">
        <label>12</label>
        <element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Quigley</surname><given-names>MR</given-names></name><name><surname>Maroon</surname><given-names>JC</given-names></name></person-group><article-title>The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas</article-title><source>Neurosurgery</source><year>1991</year><volume>29</volume><fpage>385</fpage><lpage>9</lpage><ext-link ext-link-type="doi" xlink:href="10.1097/00006123-199109000-00008">10.1097/00006123-199109000-00008</ext-link> 	<pub-id pub-id-type="pmid">1833663</pub-id></element-citation>
      </ref>
      <ref id="b13-cln_65p923">
        <label>13</label>
        <element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Hess</surname><given-names>KR</given-names></name></person-group><article-title>Extent of ressection as a prognostic variabble in the treatment of gliomas</article-title><source>J Neuro-Oncol</source><year>1999</year><volume>42</volume><fpage>227</fpage><lpage>31</lpage><ext-link ext-link-type="doi" xlink:href="10.1023/A:1006118018770">10.1023/A:1006118018770</ext-link> 	</element-citation>
      </ref>
      <ref id="b14-cln_65p923">
        <label>14</label>
        <element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Prados</surname><given-names>MD</given-names></name></person-group><article-title>Future directions in the treatment of malignant gliomas with temozolomide</article-title><source>Semin Oncol</source><year>2000</year><volume>27</volume><issue>3 Suppl 6</issue><fpage>41</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10866349</pub-id></element-citation>
      </ref>
      <ref id="b15-cln_65p923">
        <label>15</label>
        <element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Sposto</surname><given-names>R</given-names></name><name><surname>Ertel</surname><given-names>IJ</given-names></name><name><surname>Jenkin</surname><given-names>RD</given-names></name><name><surname>Boesel</surname><given-names>CP</given-names></name><name><surname>Venes</surname><given-names>JL</given-names></name><name><surname>Ortega</surname><given-names>JA</given-names></name><etal/></person-group><article-title>The effectiveness of chemotherapy for treatment of high grade astrocytomas in children: results of a randomized trial. A report from the Childrens Cancer Study Group</article-title><source>J Neurooncol</source><year>1989</year><volume>7</volume><fpage>165</fpage><lpage>77</lpage><ext-link ext-link-type="doi" xlink:href="10.1007/BF00165101">10.1007/BF00165101</ext-link> 	<pub-id pub-id-type="pmid">2550594</pub-id></element-citation>
      </ref>
      <ref id="b16-cln_65p923">
        <label>16</label>
        <element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Jakacki</surname><given-names>RI</given-names></name><name><surname>Yates</surname><given-names>A</given-names></name><name><surname>Blaney</surname><given-names>SM</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Timmerman</surname><given-names>R</given-names></name><name><surname>Ingle</surname><given-names>AM</given-names></name><etal/></person-group><article-title>A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood</article-title><source>Neuro Oncol</source><year>2008</year><volume>10</volume><fpage>569</fpage><lpage>76</lpage><ext-link ext-link-type="doi" xlink:href="10.1215/15228517-2008-019">10.1215/15228517-2008-019</ext-link> 	<pub-id pub-id-type="pmid">18497327</pub-id></element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-cln_65p923" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Skull CT: Deep-seated cerebral lesion with an irregular outline, mass-effect, peripheral contrast uptake, and central necrosis.- Skull CT: Deep-seated cerebral lesion with an irregular outline, mass-effect, peripheral contrast uptake, and central necrosis.</p>
      </caption>
      <graphic xlink:href="cln-65-09-923-g001"/>
    </fig>
    <fig id="f2-cln_65p923" position="float">
      <label>Figure 2</label>
      <caption>
        <p>A, B: Histological sections of cerebral tissue showing areas of elongated cells with pleomorphic and hyperchromatic nuclei that are associated with vascular neoformation and extensive hemorrhage and necrosis.- A, B: Histological sections of cerebral tissue showing areas of elongated cells with pleomorphic and hyperchromatic nuclei that are associated with vascular neoformation and extensive hemorrhage and necrosis.</p>
        <p>C: Immunohistochemistry positive for GFAP.</p>
      </caption>
      <graphic xlink:href="cln-65-09-923-g002"/>
    </fig>
    <fig id="f3-cln_65p923" position="float">
      <label>Figure 3</label>
      <caption>
        <p>CT (above) and MTI (below): A large lesion impinging on the thalamus and basal ganglia with peripheral contrast uptake and central necrosis.- CT (above) and MTI (below): A large lesion impinging on the thalamus and basal ganglia with peripheral contrast uptake and central necrosis.</p>
      </caption>
      <graphic xlink:href="cln-65-09-923-g003"/>
    </fig>
    <table-wrap id="t1-cln_65p923" position="float">
      <label>Table 1</label>
      <caption>
        <p>Antigens that were used for the immunohistochemistry.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Antigens</td>
            <td align="center" valign="bottom" rowspan="1" colspan="1">Clone</td>
            <td align="center" valign="bottom" rowspan="1" colspan="1">Result</td>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Glial fibrillary acidic protein (GFAP)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Policlonal</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Positive</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Ki-67 cellular proliferation antigen</td>
            <td align="left" valign="top" rowspan="1" colspan="1">M1B1</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Positive</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">S-100 protein</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Policlonal</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Positive</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Neu-N</td>
            <td align="left" valign="top" rowspan="1" colspan="1">MAB377</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Negative</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">CD45RB &#x2013; leukocyte-common antigen (pan-hematopoietic)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">PD7/26/16&amp;2B11</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Negative</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
